These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34834924)

  • 1. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge.
    Xu X; Zhang QY; Chu XY; Quan Y; Lv BM; Zhang HY
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New horizons for antiviral drug discovery from virus-host protein interaction networks.
    de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
    Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-host interactomes--antiviral drug discovery.
    Ma-Lauer Y; Lei J; Hilgenfeld R; von Brunn A
    Curr Opin Virol; 2012 Oct; 2(5):614-21. PubMed ID: 23057872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human viral diseases: what is next for antiviral drug discovery?
    De Clercq E
    Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Spirooxindoles as Antiviral Agents.
    Ye N; Chen H; Wold EA; Shi PY; Zhou J
    ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
    Naesens L; Zoulim F
    Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
    Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
    Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in Antiviral Drug Development: Comprehensive Insights into Design Strategies and Mechanisms Targeting Key Viral Proteins.
    Hangyu W; Panpan L; Jie S; Hongyan W; Linmiao W; Kangning H; Yichen S; Shuai W; Cheng W
    J Microbiol Biotechnol; 2024 Jul; 34(7):1376-1384. PubMed ID: 38934770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
    Mercorelli B; Palù G; Loregian A
    Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial overview: antivirals and resistance: advances and challenges ahead.
    Menéndez-Arias L; Richman DD
    Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
    [No Abstract]   [Full Text] [Related]  

  • 11. The program of antiviral agents inhibits virus infection.
    Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
    Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Antiviral Action of Alkaloids.
    Abookleesh FL; Al-Anzi BS; Ullah A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and future perspectives of computational studies on human-virus protein-protein interactions.
    Lian X; Yang X; Yang S; Zhang Z
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33693490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial overview: Engineering for viral resistance.
    von Brunn A
    Curr Opin Virol; 2015 Oct; 14():v-vii. PubMed ID: 26320757
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein-protein interactions as targets for antiviral chemotherapy.
    Loregian A; Marsden HS; Palù G
    Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progresses in marine microbial-derived antiviral natural products.
    Teng YF; Xu L; Wei MY; Wang CY; Gu YC; Shao CL
    Arch Pharm Res; 2020 Dec; 43(12):1215-1229. PubMed ID: 33222073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral drug resistance: mechanisms and clinical implications.
    Strasfeld L; Chou S
    Infect Dis Clin North Am; 2010 Jun; 24(2):413-37. PubMed ID: 20466277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.
    Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA.
    Vere Hodge RA
    Antiviral Res; 2014 Nov; 111():143-53. PubMed ID: 25218950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.